Get App Open
In App
Credit Cards
Open App
Success
Alert
Please select a Day.
Info

Morepen Laboratories Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

50/100
45.71
-0.57 (-1.23%)

As on 18 Nov, 2025 | 03:59

Open Trading A/c
Day Range
45.61
46.44
L H
52 Week Range
42.00
91.70
L H
Volume
1,053,766
*
i

* BSE Market Depth (18 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
20 45.71 45.75 583
410 45.70 45.80 50
2 45.68 45.82 1
100 45.67 45.89 100
100 45.66 45.93 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
50/100
45.75
-0.48 (-1.04%)

As on 18 Nov, 2025 | 04:01

Open Trading A/c
Day Range
45.60
46.31
L H
52 Week Range
41.66
91.57
L H
Volume
134,681
*
i

* BSE Market Depth (18 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
20 45.71 45.75 583
410 45.70 45.80 50
2 45.68 45.82 1
100 45.67 45.89 100
100 45.66 45.93 100
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
53% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock at Discounted Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 46.19
          Previous Close 46.28
          Volume 1,053,766.00
          Value (Lacs) 481.68
            VWAP 45.86
          Beta
          Mkt Cap (Rs. Cr.) 2,505
          High 46.44
          Low 45.61
          UC Limit 55.53
          LC Limit 37.02
          52 Week High 91.70
          52 Week Low 42.00
          Face Value 2.00
          All Time High 840.00
          All Time Low 2.05
          20D Avg Volume 1,310,110
          20D Avg Delivery(%) 46.72
          Book Value Per Share 21.10
          Dividend Yield 0.44
          TTM EPS See historical trend 1.80 (-24.87% YoY)
          TTM PE See historical trend 25.39 (Low PE)
          P/B See historical trend 2.17 (Low P/B)
          Sector PE 40.31

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          50/100
          Average Financial Strength, Average Growth Trend Stock at Discounted Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 50.15% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 35.65% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 17 years Morepen Laboratories has given negative returns in November.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          November 38.11% (2015) 20.57% -19.42% (2014) -8.11% 5.39%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Morepen Lab

          What's your call on Morepen Lab today?

          Read 2 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          28 Apr, 2025

          Graviton Research Capital Llp

          Qty 3077570 Price 62.36 % Traded 0.56
          28 Apr, 2025

          Graviton Research Capital Llp

          Qty 3077570 Price 62.4 % Traded 0.56
          24 Apr, 2025

          Graviton Research Capital Llp

          Qty 4332551 Price 60.53 % Traded 0.77
          24 Apr, 2025

          Graviton Research Capital Llp

          Qty 4332551 Price 60.5 % Traded 0.77
          18 Mar, 2025

          Graviton Research Capital Llp

          Qty 3617786 Price 47.96 % Traded 0.65
          18 Mar, 2025

          Graviton Research Capital Llp

          Qty 3617786 Price 47.98 % Traded 0.65
          11 Nov, 2024

          Graviton Research Capital Llp

          Qty 2906229 Price 83.13 % Traded 0.55
          11 Nov, 2024

          Graviton Research Capital Llp

          Qty 2906229 Price 83.04 % Traded 0.55

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Morepen Lab 45.71 -1.23 2,504.70 25.39 2.17 10.20 -38.35 118 1,811 0.07
          Sun Pharma 1,758.80 -0.29 421,995.03 40.39 5.84 15.13 0.63 10,980 52,578 0.03
          Divis Labs 6,473.50 -0.69 171,851.09 69.15 11.48 14.63 12.26 2,191 9,360 0.00
          Torrent Pharma 3,790.80 -0.75 128,297.90 59.95 17.10 25.17 22.06 1,911 11,516 0.40
          Cipla 1,514.50 -1.37 122,336.95 22.48 3.92 16.90 3.36 5,291 27,547 0.00

          About the Company

          Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast. It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.
          {"success":1,"data":{"address":{"address1":"Morepen Village,","address2":",","city":"Solan District","state":"Himachal Pradesh","pincode":"173205","telephone1":"01795-276201","telephone2":"01795-276202","fax1":"01795-276204","fax2":"","email":"investors@morepen.com","web":"http:\/\/www.morepen.com"},"management":[{"name":"Sushil Suri","designation":"Chairman & Managing Director"},{"name":"Sanjay Suri","designation":"Whole Time Director"},{"name":"Praveen Kumar Dutt","designation":"Independent Director"},{"name":"Savita","designation":"Independent Director"},{"name":"Ranjit Khattar","designation":"Independent Director"}],"registrars":{"name":"Mas Services Ltd.","address1":"T-34, 2nd Floor,","address2":"Oklha Industrial Area,,","address3":"Phase - II,","address4":"","telephone":"011-26387281, 26387282, 26387283","fax":"011-26387384","email":"info@masserv.com","internet":"http:\/\/www.masserv.com","city":"New Delhi","state":"Delhi","pincode":"110020"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"500288","nseId":"MOREPENLAB","series":"EQ","isinid":"INE083A01026"}}}
          • Registered Office

          • Registrars

            • Address

              T-34, 2nd Floor,,Oklha Industrial Area,,

            • City

              New Delhi 110020

            • State

              Delhi

            • Tel. No.

              011-26387281, 26387282, 26387283

            • Fax No.

              011-26387384

            • Email

              info@masserv.com

            • Internet

              http://www.masserv.com

          • Management

            • Sushil Suri

              Chairman & Managing Director

            • Sanjay Suri

              Whole Time Director

            • Praveen Kumar Dutt

              Independent Director

            • Savita

              Independent Director

            • Ranjit Khattar

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              500288

            • NSE:

              MOREPENLAB

            • Series

              EQ

            • ISIN

              INE083A01026

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347